Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Data Collection × Dermatologic × 90 days × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 2 Tumor-Agnostic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Uveal Melanoma 1

Interventions

pembrolizumab 62 Nivolumab 57 Ipilimumab 30 Specimen Handling 26 Magnetic Resonance Spectroscopy 24 Cyclophosphamide 22 Biopsy 19 fludarabine 16 cemiplimab 15 trametinib 13 relatlimab 12 Interleukin-2 12 aldesleukin 11 CTLA-4 Antigen 10 fludarabine phosphate 9 binimetinib 8 Opdualag 8 dabrafenib 7 Radiosurgery 7 encorafenib 6 avelumab 6 atezolizumab 6 Temozolomide 6 Radiotherapy 5 Introns 5 Immunoglobulin G 5 Aminolevulinic Acid 5 cobimetinib 4 Surgical Procedures, Operative 4 Standard of Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06432660 2026-02-06

PROMPT

Duke University

Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡